Thrilled to share news of the closing of a $320M Series D financing co-led by Patient Square Capital and Premji Invest. Thank you to all of our investors and welcome to Akshay Rai to our Board of Directors! Learn more here: https://t.co/unK7g2dOsr
Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study - Research and Practice in Thrombosis and Haemostasis https://t.co/UuVDD24hfK
💥💥ANNOUNCING THE ENIAC NETWORK💥💥
"your network is your net worth"
we learned this through building startups for two decades+, including our startup @EniacVC
and today, we're open-sourcing *our* network with founders in/out of our portfolio:
👉🏾 https://t.co/10HUwojmqu
Kriya Therapeutics has licensed an emerging #genetherapy for people with dry AMD from @MUSCatalystNews. The Foundation is funding MUSC’s Dr. Bärb Rohrer to evaluate the treatment in a large animal model, an important step toward launching a #clinicaltrial. https://t.co/xbH4QREsvx
I’m excited to announce Primer’s $110M Series C led by Addition. This capital will help us bring our NLP and AI technology to more organizations worldwide. A huge thank you to the team at Primer, our investors, and our customers for making this possible https://t.co/tTIORnGjq8
AFFIRM's #Reframe event is a community-centered discussion about gun violence prevention in various settings and situations. We're looking forward to our 2nd event in East Village, Manhattan on March 11th.
Check out the venue!
Mark your calendars! AIRWAY returns to Von Bar on October 22 as THE pre-event social for the Fall 2019 @AllNYCEM Conference. Doors open at 7pm. https://t.co/J2C9nquu7Y